1-8 of 8
Nicole Feller
Close
Sort by
Journal Articles

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

Anna van Rhenen, Guus A. M. S. van Dongen, Angèle Kelder, Elwin J. Rombouts, Nicole Feller, Bijan Moshaver, Marijke Stigter-van Walsum, Sonja Zweegman, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Blood
Blood (2007) 110 (7): 2659–2666.
https://doi.org/10.1182/blood-2007-03-083048
Published: 2007
Journal Articles

In Acute Myeloid Leukemia Both Malignant and Normal Stem Cells Can Be Detected in Remission Bone Marrow.

Anna van Rhenen, Nicole Feller, PhD, Angele Kelder, Bijan Moshaver, Sonja Zweegman, PhD MD, Gert Ossenkoppele, PhD MD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2006) 108 (11): 2537.
https://doi.org/10.1182/blood.V108.11.2537.2537
Published: 2006
Journal Articles

Identification of Primitive Subpopulations of Acute Myeloid Leukemia Side Population (SP) Stem Cells Defined by Differentiation Status and Malignant Character.

Bijan Moshaver, Marjolein A. van der Pol, PhD, Guus H. Westra, Nicole Feller, PhD, Angele Kelder, Anna van Rhenen, Gert J. Ossenkoppele, MD,PhD, Sonja Zweegman, MD,PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2006) 108 (11): 2538.
https://doi.org/10.1182/blood.V108.11.2538.2538
Published: 2006
Journal Articles

High CLIP (Class II Associated Invariant Chain Peptide) Expression on Minimal Residual Disease Cells Is Associated with High Relapse Rate in AML Patients.

Martine E. Chamuleau, MD, Nicole Feller, PhD, Angel Kelder, Arjan A. Van de Loosdrecht, MD, PhD, Gert J. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2300.
https://doi.org/10.1182/blood.V108.11.2300.2300
Published: 2006
Journal Articles

Acute Myeloid Leukemia Remission Bone Marrow Reveals the Presence of Malignant and Normal Side Population (SP) Stem Cells Whose Frequencies and Ratios Predict Clinical Outcome.

Bijan Moshaver, Marjolein A. van der Pol, PhD, Guus H. Westra, Nicole Feller, PhD, Angele Kelder, Anna van Rhenen, Gert J. Ossenkoppele, MD,PhD, Sonja Zweegman, MD,PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2006) 108 (11): 2314.
https://doi.org/10.1182/blood.V108.11.2314.2314
Published: 2006
Journal Articles

Immunophenotypical Minimal Residual Disease as a Short Term Endpoint for Monitoring Effects of Targeted Inhibitors in Acute Myeloid Leukemia.

Corine J. Hess, Nicole Feller, Fedor Denkers, Pauline A. Merle, Gert J. Ossenkoppele, PhD, Quinten Waisfisz, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2005) 106 (11): 545.
https://doi.org/10.1182/blood.V106.11.545.545
Published: 2005
Journal Articles

The Novel AML Stem Cell Associated Antigen CLL-1 Discriminates between Normal and Leukemic Stem Cells.

Anna van Rhenen, Nicole Feller, Angèle Kelder, Guus Westra, Lex Bakker, PhD, Gert Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2005) 106 (11): 4.
https://doi.org/10.1182/blood.V106.11.4.4
Published: 2005
Journal Articles

Immunophenotypical Sequential MRD Assessment in AML for Prediction of Relapse and Definition of Putative Future Intervention Time Points.

Nicole Feller, Peter C. Huijgens, MD, PhD, Angele Kelder, Guus Westra, Gert Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2004) 104 (11): 3012.
https://doi.org/10.1182/blood.V104.11.3012.3012
Published: 2004